Leading the Way in Sustainable Pharma Practices: SCHOTT Pharma Unveils Inaugural Sustainability Report Aligned with GRI Standards
SCHOTT Pharma, a global frontrunner in drug containment solutions and delivery systems for injectable drugs, takes a monumental stride towards transparency and corporate responsibility by launching its first-ever Sustainability Report for the fiscal year 2023. The report, meticulously aligned with the Global Reporting Initiative (GRI) Standards, goes beyond conventional business metrics, providing stakeholders with a comprehensive view of the company’s commitment to sustainable development and ethical business governance.
In an era where sustainability is a defining factor for industry leaders, SCHOTT Pharma’s digital report stands as a testament to the company’s unwavering dedication to addressing sustainability as a core business priority. The report is structured thematically, delving into Business Responsibility, Workforce Responsibility, Social Responsibility, and Environmental Responsibility, offering a multifaceted perspective on the company’s sustainability initiatives.
A notable highlight in the report is SCHOTT Pharma’s mission, encapsulated in the powerful statement, “Because human health matters.” It emphasizes the pivotal role the company plays in delivering high-quality product solutions that ensure the safe storage and administration of systemically relevant medicine. Beyond the confines of the pharmaceutical industry, SCHOTT Pharma extends its commitment to achieving climate neutrality by 2030, a goal backed by impressive achievements such as 100 percent green electricity usage and a remarkable 60 percent reduction in CO2 emissions in Scope 1 and 2.
The report also sheds light on the company’s Social Responsibility endeavors, showcasing a dedication to fostering an attractive working environment and championing diversity, equality, and inclusion. The commitment to strong Corporate Governance is underscored, with a focus on anti-corruption measures and clear policies aligned with the principles of the United Nations Global Compact for sustainable and responsible business. SCHOTT Pharma further extends these values throughout its value chain, ensuring a holistic integration of sustainability practices. 
Taking a holistic view, SCHOTT Pharma’s Sustainability Report delves into crucial aspects such as waste management, water conservation, environmental protection, occupational safety, and health initiatives. These material topics are meticulously addressed based on a thorough double-materiality analysis, emphasizing the company’s commitment to responsible and sustainable business practices.
As SCHOTT Pharma sets new standards in the pharmaceutical industry, this Sustainability Report serves as a beacon of transparency, accountability, and a roadmap for future sustainable endeavors.
Source: GlassBalkan
